|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"yen fs"
Showing items 16-40 of 90 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-11-14 |
Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study
|
Yen, FS;Wei, JCC;Wu, YL;Lo, YR;Chen, CM;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-1016 |
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
|
Yen, FS;Hsu, CC;Wei, JCC;Tsai, FJ;Huang, YH;Yu, TS;Hwu, CM |
| 國家衛生研究院 |
2024-09-10 |
The effect of sodium-glucose cotransporter-2 inhibitors on graft survival and cardiorenal outcomes in patients with diabetes and heart transplantation
|
Hwu, CM;Yen, FS;Huang, JY;Hsu, CC;Cheng, WY;Wei, JC |
| 國家衛生研究院 |
2024-08-29 |
Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan
|
Yen, YH;Yen, FS;Ko, FS;Wei, JCC;Huang, YH;Yu, TS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-08-08 |
Glucagon-like peptide-1 receptor agonists and risk of sight-threatening retinopathy in Taiwanese population: A propensity based cohort study
|
Yen, FS;Wei, JC;Shih, YH;Hung, YT;Hsu, TJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2024-06-12 |
Sodium-glucose cotransporter-2 inhibitors and nephritis among patients with systemic lupus erythematosus
|
Yen, FS;Wang, SI;Hsu, CC;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2024-04-30 |
Sodium-glucose cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease
|
Yen, FS;Hwu, CM;Liu, JS;Wu, YL;Chong, K;Hsu, CC |
| 國家衛生研究院 |
2024-04 |
Metformin and the risks of cellulitis, foot infections, and amputation in patients with type 2 diabetes
|
Yeh, YK;Yen, FS;Wei, JC;Hu, KC;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2024-01-04 |
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-12-20 |
Sodium-glucose cotransporter 2 inhibitors and risk of retinopathy in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yu, TS;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-11-30 |
Parental income level and risk of developing type 2 diabetes in youth
|
Yen, FS;Wei, JCC;Liu, JS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-10-31 |
Reply
|
Yen, FS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-09-21 |
Reply to the Letter to the Editor: "Glucagon-like Peptide-1 Receptor Agonists: Best Choice for Patients with Cirrhosis and Diabetes?"
|
Yen, FS;Yu, TS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-06-16 |
Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes
|
Yen, FS;Hou, MC;Cheng-Chung Wei, J;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-05-09 |
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Shih, YH;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-02-17 |
Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-01-04 |
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
|
Yen, FS;Hou, MC;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-01 |
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yip, HT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-01 |
The risk of severe hypoglycemia and mortality in patients with type 2 diabetes and discharged with acute liver injury
|
Yen, FS;Hou, MC;Pan, CW;Liu, JS;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-12-21 |
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11-15 |
Sulfonylurea use in patients with type 2 diabetes and COPD: A nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Yu, TS;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11 |
Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-10-19 |
Metformin use before influenza vaccination may lower the risks of influenza and related complications
|
Yen, FS;Wei, JC;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-09-03 |
Metformin and the risk of chronic urticaria in patients with type 2 diabetes
|
Yen, FS;Hsu, CC;Hu, KC;Hung, YT;Hsu, CY;Wei, JC;Hwu, CM |
| 國家衛生研究院 |
2022-08-22 |
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JCC;Chiu, LT;Hsu, CC;Hwu, CM |
Showing items 16-40 of 90 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
